Literature DB >> 26551740

Regulation of TRPC6 ion channels in podocytes - Implications for focal segmental glomerulosclerosis and acquired forms of proteinuric diseases.

T Szabó1, L Ambrus2, N Zákány2, Gy Balla1, T Bíró2.   

Abstract

The glomerular filtration barrier is a highly specialized tri-layer structure with unique functional properties. Podocyte dysfunction and cytoskeletal disorganization leads to disruption of the slit diaphragma, and proteinuria. Inflammatory diseases involving the kidney as well as inherited podocytopathies or diabetic nephropathy cause injury of the podocyte network. Focal segmental glomerulosclerosis (FSGS) is a pathologic entity that is a common cause of nephrotic syndrome with severe proteinuria in both adults and children. Several causative genes have been identified in the pathogenesis of FSGS. Mutations of the transient receptor potential canonical-6 (TRPC6), a non-selective cation channel that is directly activated by diacylglycerol (DAG), cause a particularly aggressive form of FSGS. Angiotensin II, acting through its AT1 receptor, plays a critical role in generation of proteinuria and progression of kidney injury in a number of kidney diseases, including FSGS. Mounting evidence suggest the central role of TRPC6 and perhaps other TRPC channels in the pathogenesis of FSGS as well as of acquired forms of proteinuria such as diabetic nephropathy or hypertension. Identification of signaling pathways downstream of TRPC6 may provide novel targets for the treatment of proteinuria and prevent progression of podocyte injury.

Entities:  

Keywords:  TRPC6; angiotensin II; diabetic nephropathy; focal segmental glomerulosclerosis (FSGS); podocyte; proteinuric disease

Mesh:

Substances:

Year:  2015        PMID: 26551740     DOI: 10.1556/036.102.2015.3.2

Source DB:  PubMed          Journal:  Acta Physiol Hung        ISSN: 0231-424X


  7 in total

1.  Pharmacological inhibition of focal segmental glomerulosclerosis-related, gain of function mutants of TRPC6 channels by semi-synthetic derivatives of larixol.

Authors:  Nicole Urban; Sonja Neuser; Anika Hentschel; Sebastian Köhling; Jörg Rademann; Michael Schaefer
Journal:  Br J Pharmacol       Date:  2017-10-15       Impact factor: 8.739

2.  The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Bradley T Endres; Alexander Staruschenko
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

Review 3.  Research Progress in Acute Hypertensive Renal Injury by "in Vivo Cryotechnique".

Authors:  Da Sun; Jiaojiao Wang; Li Yao; Zilong Li; Shinichi Ohno
Journal:  J Transl Int Med       Date:  2019-12-31

4.  Pathogenesis and Damage Targets of Hypertensive Kidney Injury.

Authors:  Da Sun; Jiaojiao Wang; Wansong Shao; Juan Wang; Li Yao; Zilong Li; Shinichi Ohno
Journal:  J Transl Int Med       Date:  2020-12-31

Review 5.  Focusing on Mechanoregulation Axis in Fibrosis: Sensing, Transduction and Effecting.

Authors:  Dongsheng Wen; Ya Gao; Chiakang Ho; Li Yu; Yuguang Zhang; Guozhong Lyu; Dahai Hu; Qingfeng Li; Yifan Zhang
Journal:  Front Mol Biosci       Date:  2022-03-11

6.  Tetrandrine Attenuates Podocyte Injury by Inhibiting TRPC6-Mediated RhoA/ROCK1 Pathway.

Authors:  Lichan Mao; Yin Ding; Dongrong Yu; Jiazhen Yin; Jin Yu
Journal:  Anal Cell Pathol (Amst)       Date:  2022-09-30       Impact factor: 4.133

7.  Tetrandrine Suppresses Transient Receptor Potential Cation Channel Protein 6 Overexpression- Induced Podocyte Damage via Blockage of RhoA/ROCK1 Signaling.

Authors:  Jin Yu; Caifeng Zhu; Jiazhen Yin; Dongrong Yu; Feng Wan; Xuanli Tang; Xue Jiang
Journal:  Drug Des Devel Ther       Date:  2020-01-28       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.